Report Detail
Global Benign Prostatic Hyperplasia Devices Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030
- RnM4602562 |
- 20 July, 2024 |
- Global |
- 99 Pages |
- GIR (Global Info Research) |
- Medical Devices & Consumables
According to our (Global Info Research) latest study, the global Benign Prostatic Hyperplasia Devices market size was valued at USD 392 million in 2023 and is forecast to a readjusted size of USD 513.5 million by 2030 with a CAGR of 3.9% during review period.
Benign prostatic hyperplasia (BPH) is a urological disorder characterized by non-cancerous proliferation of prostate gland cells. This condition causes the gland to enlarge and, as a result, press against the urethra, constricting urine flow. This disorder is associated with aging, hormone imbalances, and abnormal cell growth.
The global benign prostatic hyperplasia market is expected to show considerable growth during the forecast period. This is attributed to rising geriatric population, increased awareness for prostate cancer and other urological disorders. However, the factors such as dearth of urologist in developing economies and lack of awareness regarding various urological diseases can hinder the growth of the market in the coming years. North America is account for the largest share of the benign prostatic hyperplasia market in 2016 due to high prevalence rate of benign prostatic hyperplasia. However, Asia is the fastest growing market due to the rise in various urological disorders and complications
The Global Info Research report includes an overview of the development of the Benign Prostatic Hyperplasia Devices industry chain, the market status of Hospitals and Clinics (Transurethral Resection of the Prostate (TURP), Transurethral Microwave Therapy (TUMT)), Ambulatory Surgical Centers(ASC) (Transurethral Resection of the Prostate (TURP), Transurethral Microwave Therapy (TUMT)), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Benign Prostatic Hyperplasia Devices.
Regionally, the report analyzes the Benign Prostatic Hyperplasia Devices markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Benign Prostatic Hyperplasia Devices market, with robust domestic demand, supportive policies, and a strong manufacturing base.
Key Features:
The report presents comprehensive understanding of the Benign Prostatic Hyperplasia Devices market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Benign Prostatic Hyperplasia Devices industry.
The report involves analyzing the market at a macro level:
Market Sizing and Segmentation: Report collect data on the overall market size, including the sales quantity (K Units), revenue generated, and market share of different by Type (e.g., Transurethral Resection of the Prostate (TURP), Transurethral Microwave Therapy (TUMT)).
Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Benign Prostatic Hyperplasia Devices market.
Regional Analysis: The report involves examining the Benign Prostatic Hyperplasia Devices market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.
Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Benign Prostatic Hyperplasia Devices market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.
The report also involves a more granular approach to Benign Prostatic Hyperplasia Devices:
Company Analysis: Report covers individual Benign Prostatic Hyperplasia Devices manufacturers, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.
Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Benign Prostatic Hyperplasia Devices This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Hospitals and Clinics, Ambulatory Surgical Centers(ASC)).
Technology Analysis: Report covers specific technologies relevant to Benign Prostatic Hyperplasia Devices. It assesses the current state, advancements, and potential future developments in Benign Prostatic Hyperplasia Devices areas.
Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Benign Prostatic Hyperplasia Devices market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.
Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.
Market Segmentation
Benign Prostatic Hyperplasia Devices market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.
Market segment by Type
Transurethral Resection of the Prostate (TURP)
Transurethral Microwave Therapy (TUMT)
Transurethral Needle Ablation of the Prostate (TUNA)
Laser Surgery
Prostatic Stenting
Others
Market segment by Application
Hospitals and Clinics
Ambulatory Surgical Centers(ASC)
Home
Others
Major players covered
Lumenis
Olympus corporation
Urologix
Boston Scientific corporation
Lisa Laser
Medifocus
Neotrac
ProArc Medical LTD
Urotech GMBH
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Benign Prostatic Hyperplasia Devices product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Benign Prostatic Hyperplasia Devices, with price, sales, revenue and global market share of Benign Prostatic Hyperplasia Devices from 2019 to 2024.
Chapter 3, the Benign Prostatic Hyperplasia Devices competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Benign Prostatic Hyperplasia Devices breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2019 to 2030.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2019 to 2030.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2023.and Benign Prostatic Hyperplasia Devices market forecast, by regions, type and application, with sales and revenue, from 2025 to 2030.
Chapter 12, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Benign Prostatic Hyperplasia Devices.
Chapter 14 and 15, to describe Benign Prostatic Hyperplasia Devices sales channel, distributors, customers, research findings and conclusion.
1 Market Overview
- 1.1 Product Overview and Scope of Benign Prostatic Hyperplasia Devices
- 1.2 Market Estimation Caveats and Base Year
- 1.3 Market Analysis by Type
- 1.3.1 Overview: Global Benign Prostatic Hyperplasia Devices Consumption Value by Type: 2019 Versus 2023 Versus 2030
- 1.3.2 Transurethral Resection of the Prostate (TURP)
- 1.3.3 Transurethral Microwave Therapy (TUMT)
- 1.3.4 Transurethral Needle Ablation of the Prostate (TUNA)
- 1.3.5 Laser Surgery
- 1.3.6 Prostatic Stenting
- 1.3.7 Others
- 1.4 Market Analysis by Application
- 1.4.1 Overview: Global Benign Prostatic Hyperplasia Devices Consumption Value by Application: 2019 Versus 2023 Versus 2030
- 1.4.2 Hospitals and Clinics
- 1.4.3 Ambulatory Surgical Centers(ASC)
- 1.4.4 Home
- 1.4.5 Others
- 1.5 Global Benign Prostatic Hyperplasia Devices Market Size & Forecast
- 1.5.1 Global Benign Prostatic Hyperplasia Devices Consumption Value (2019 & 2023 & 2030)
- 1.5.2 Global Benign Prostatic Hyperplasia Devices Sales Quantity (2019-2030)
- 1.5.3 Global Benign Prostatic Hyperplasia Devices Average Price (2019-2030)
2 Manufacturers Profiles
- 2.1 Lumenis
- 2.1.1 Lumenis Details
- 2.1.2 Lumenis Major Business
- 2.1.3 Lumenis Benign Prostatic Hyperplasia Devices Product and Services
- 2.1.4 Lumenis Benign Prostatic Hyperplasia Devices Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
- 2.1.5 Lumenis Recent Developments/Updates
- 2.2 Olympus corporation
- 2.2.1 Olympus corporation Details
- 2.2.2 Olympus corporation Major Business
- 2.2.3 Olympus corporation Benign Prostatic Hyperplasia Devices Product and Services
- 2.2.4 Olympus corporation Benign Prostatic Hyperplasia Devices Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
- 2.2.5 Olympus corporation Recent Developments/Updates
- 2.3 Urologix
- 2.3.1 Urologix Details
- 2.3.2 Urologix Major Business
- 2.3.3 Urologix Benign Prostatic Hyperplasia Devices Product and Services
- 2.3.4 Urologix Benign Prostatic Hyperplasia Devices Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
- 2.3.5 Urologix Recent Developments/Updates
- 2.4 Boston Scientific corporation
- 2.4.1 Boston Scientific corporation Details
- 2.4.2 Boston Scientific corporation Major Business
- 2.4.3 Boston Scientific corporation Benign Prostatic Hyperplasia Devices Product and Services
- 2.4.4 Boston Scientific corporation Benign Prostatic Hyperplasia Devices Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
- 2.4.5 Boston Scientific corporation Recent Developments/Updates
- 2.5 Lisa Laser
- 2.5.1 Lisa Laser Details
- 2.5.2 Lisa Laser Major Business
- 2.5.3 Lisa Laser Benign Prostatic Hyperplasia Devices Product and Services
- 2.5.4 Lisa Laser Benign Prostatic Hyperplasia Devices Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
- 2.5.5 Lisa Laser Recent Developments/Updates
- 2.6 Medifocus
- 2.6.1 Medifocus Details
- 2.6.2 Medifocus Major Business
- 2.6.3 Medifocus Benign Prostatic Hyperplasia Devices Product and Services
- 2.6.4 Medifocus Benign Prostatic Hyperplasia Devices Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
- 2.6.5 Medifocus Recent Developments/Updates
- 2.7 Neotrac
- 2.7.1 Neotrac Details
- 2.7.2 Neotrac Major Business
- 2.7.3 Neotrac Benign Prostatic Hyperplasia Devices Product and Services
- 2.7.4 Neotrac Benign Prostatic Hyperplasia Devices Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
- 2.7.5 Neotrac Recent Developments/Updates
- 2.8 ProArc Medical LTD
- 2.8.1 ProArc Medical LTD Details
- 2.8.2 ProArc Medical LTD Major Business
- 2.8.3 ProArc Medical LTD Benign Prostatic Hyperplasia Devices Product and Services
- 2.8.4 ProArc Medical LTD Benign Prostatic Hyperplasia Devices Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
- 2.8.5 ProArc Medical LTD Recent Developments/Updates
- 2.9 Urotech GMBH
- 2.9.1 Urotech GMBH Details
- 2.9.2 Urotech GMBH Major Business
- 2.9.3 Urotech GMBH Benign Prostatic Hyperplasia Devices Product and Services
- 2.9.4 Urotech GMBH Benign Prostatic Hyperplasia Devices Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
- 2.9.5 Urotech GMBH Recent Developments/Updates
3 Competitive Environment: Benign Prostatic Hyperplasia Devices by Manufacturer
- 3.1 Global Benign Prostatic Hyperplasia Devices Sales Quantity by Manufacturer (2019-2024)
- 3.2 Global Benign Prostatic Hyperplasia Devices Revenue by Manufacturer (2019-2024)
- 3.3 Global Benign Prostatic Hyperplasia Devices Average Price by Manufacturer (2019-2024)
- 3.4 Market Share Analysis (2023)
- 3.4.1 Producer Shipments of Benign Prostatic Hyperplasia Devices by Manufacturer Revenue ($MM) and Market Share (%): 2023
- 3.4.2 Top 3 Benign Prostatic Hyperplasia Devices Manufacturer Market Share in 2023
- 3.4.2 Top 6 Benign Prostatic Hyperplasia Devices Manufacturer Market Share in 2023
- 3.5 Benign Prostatic Hyperplasia Devices Market: Overall Company Footprint Analysis
- 3.5.1 Benign Prostatic Hyperplasia Devices Market: Region Footprint
- 3.5.2 Benign Prostatic Hyperplasia Devices Market: Company Product Type Footprint
- 3.5.3 Benign Prostatic Hyperplasia Devices Market: Company Product Application Footprint
- 3.6 New Market Entrants and Barriers to Market Entry
- 3.7 Mergers, Acquisition, Agreements, and Collaborations
4 Consumption Analysis by Region
- 4.1 Global Benign Prostatic Hyperplasia Devices Market Size by Region
- 4.1.1 Global Benign Prostatic Hyperplasia Devices Sales Quantity by Region (2019-2030)
- 4.1.2 Global Benign Prostatic Hyperplasia Devices Consumption Value by Region (2019-2030)
- 4.1.3 Global Benign Prostatic Hyperplasia Devices Average Price by Region (2019-2030)
- 4.2 North America Benign Prostatic Hyperplasia Devices Consumption Value (2019-2030)
- 4.3 Europe Benign Prostatic Hyperplasia Devices Consumption Value (2019-2030)
- 4.4 Asia-Pacific Benign Prostatic Hyperplasia Devices Consumption Value (2019-2030)
- 4.5 South America Benign Prostatic Hyperplasia Devices Consumption Value (2019-2030)
- 4.6 Middle East and Africa Benign Prostatic Hyperplasia Devices Consumption Value (2019-2030)
5 Market Segment by Type
- 5.1 Global Benign Prostatic Hyperplasia Devices Sales Quantity by Type (2019-2030)
- 5.2 Global Benign Prostatic Hyperplasia Devices Consumption Value by Type (2019-2030)
- 5.3 Global Benign Prostatic Hyperplasia Devices Average Price by Type (2019-2030)
6 Market Segment by Application
- 6.1 Global Benign Prostatic Hyperplasia Devices Sales Quantity by Application (2019-2030)
- 6.2 Global Benign Prostatic Hyperplasia Devices Consumption Value by Application (2019-2030)
- 6.3 Global Benign Prostatic Hyperplasia Devices Average Price by Application (2019-2030)
7 North America
- 7.1 North America Benign Prostatic Hyperplasia Devices Sales Quantity by Type (2019-2030)
- 7.2 North America Benign Prostatic Hyperplasia Devices Sales Quantity by Application (2019-2030)
- 7.3 North America Benign Prostatic Hyperplasia Devices Market Size by Country
- 7.3.1 North America Benign Prostatic Hyperplasia Devices Sales Quantity by Country (2019-2030)
- 7.3.2 North America Benign Prostatic Hyperplasia Devices Consumption Value by Country (2019-2030)
- 7.3.3 United States Market Size and Forecast (2019-2030)
- 7.3.4 Canada Market Size and Forecast (2019-2030)
- 7.3.5 Mexico Market Size and Forecast (2019-2030)
8 Europe
- 8.1 Europe Benign Prostatic Hyperplasia Devices Sales Quantity by Type (2019-2030)
- 8.2 Europe Benign Prostatic Hyperplasia Devices Sales Quantity by Application (2019-2030)
- 8.3 Europe Benign Prostatic Hyperplasia Devices Market Size by Country
- 8.3.1 Europe Benign Prostatic Hyperplasia Devices Sales Quantity by Country (2019-2030)
- 8.3.2 Europe Benign Prostatic Hyperplasia Devices Consumption Value by Country (2019-2030)
- 8.3.3 Germany Market Size and Forecast (2019-2030)
- 8.3.4 France Market Size and Forecast (2019-2030)
- 8.3.5 United Kingdom Market Size and Forecast (2019-2030)
- 8.3.6 Russia Market Size and Forecast (2019-2030)
- 8.3.7 Italy Market Size and Forecast (2019-2030)
9 Asia-Pacific
- 9.1 Asia-Pacific Benign Prostatic Hyperplasia Devices Sales Quantity by Type (2019-2030)
- 9.2 Asia-Pacific Benign Prostatic Hyperplasia Devices Sales Quantity by Application (2019-2030)
- 9.3 Asia-Pacific Benign Prostatic Hyperplasia Devices Market Size by Region
- 9.3.1 Asia-Pacific Benign Prostatic Hyperplasia Devices Sales Quantity by Region (2019-2030)
- 9.3.2 Asia-Pacific Benign Prostatic Hyperplasia Devices Consumption Value by Region (2019-2030)
- 9.3.3 China Market Size and Forecast (2019-2030)
- 9.3.4 Japan Market Size and Forecast (2019-2030)
- 9.3.5 Korea Market Size and Forecast (2019-2030)
- 9.3.6 India Market Size and Forecast (2019-2030)
- 9.3.7 Southeast Asia Market Size and Forecast (2019-2030)
- 9.3.8 Australia Market Size and Forecast (2019-2030)
10 South America
- 10.1 South America Benign Prostatic Hyperplasia Devices Sales Quantity by Type (2019-2030)
- 10.2 South America Benign Prostatic Hyperplasia Devices Sales Quantity by Application (2019-2030)
- 10.3 South America Benign Prostatic Hyperplasia Devices Market Size by Country
- 10.3.1 South America Benign Prostatic Hyperplasia Devices Sales Quantity by Country (2019-2030)
- 10.3.2 South America Benign Prostatic Hyperplasia Devices Consumption Value by Country (2019-2030)
- 10.3.3 Brazil Market Size and Forecast (2019-2030)
- 10.3.4 Argentina Market Size and Forecast (2019-2030)
11 Middle East & Africa
- 11.1 Middle East & Africa Benign Prostatic Hyperplasia Devices Sales Quantity by Type (2019-2030)
- 11.2 Middle East & Africa Benign Prostatic Hyperplasia Devices Sales Quantity by Application (2019-2030)
- 11.3 Middle East & Africa Benign Prostatic Hyperplasia Devices Market Size by Country
- 11.3.1 Middle East & Africa Benign Prostatic Hyperplasia Devices Sales Quantity by Country (2019-2030)
- 11.3.2 Middle East & Africa Benign Prostatic Hyperplasia Devices Consumption Value by Country (2019-2030)
- 11.3.3 Turkey Market Size and Forecast (2019-2030)
- 11.3.4 Egypt Market Size and Forecast (2019-2030)
- 11.3.5 Saudi Arabia Market Size and Forecast (2019-2030)
- 11.3.6 South Africa Market Size and Forecast (2019-2030)
12 Market Dynamics
- 12.1 Benign Prostatic Hyperplasia Devices Market Drivers
- 12.2 Benign Prostatic Hyperplasia Devices Market Restraints
- 12.3 Benign Prostatic Hyperplasia Devices Trends Analysis
- 12.4 Porters Five Forces Analysis
- 12.4.1 Threat of New Entrants
- 12.4.2 Bargaining Power of Suppliers
- 12.4.3 Bargaining Power of Buyers
- 12.4.4 Threat of Substitutes
- 12.4.5 Competitive Rivalry
13 Raw Material and Industry Chain
- 13.1 Raw Material of Benign Prostatic Hyperplasia Devices and Key Manufacturers
- 13.2 Manufacturing Costs Percentage of Benign Prostatic Hyperplasia Devices
- 13.3 Benign Prostatic Hyperplasia Devices Production Process
- 13.4 Benign Prostatic Hyperplasia Devices Industrial Chain
14 Shipments by Distribution Channel
- 14.1 Sales Channel
- 14.1.1 Direct to End-User
- 14.1.2 Distributors
- 14.2 Benign Prostatic Hyperplasia Devices Typical Distributors
- 14.3 Benign Prostatic Hyperplasia Devices Typical Customers
15 Research Findings and Conclusion
16 Appendix
- 16.1 Methodology
- 16.2 Research Process and Data Source
Summary:
Get latest Market Research Reports on Benign Prostatic Hyperplasia Devices. Industry analysis & Market Report on Benign Prostatic Hyperplasia Devices is a syndicated market report, published as Global Benign Prostatic Hyperplasia Devices Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030. It is complete Research Study and Industry Analysis of Benign Prostatic Hyperplasia Devices market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
